Finance

Beta
Lists
OTLK:NASDAQ
Outlook Therapeutics Inc
$1.57
-6.55%
(-0.11) 1D
$1.59
+1.22% (+0.019)
After hours
Closed: Jul 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OTLK...
Open
$1.67
High
$1.68
Low
$1.55
Mkt. cap
251.43M
Avg. vol.
22.48M
Volume
7.35M
52-wk high
$3.39
52-wk low
$0.16
EPS
-$1.26
Beta
0.77
Shares outstanding
160.15M
No. of employees
17
Open
$1.67
High
$1.68
Low
$1.55
Mkt. cap
251.43M
Avg. vol.
22.48M
Volume
7.35M
52-wk high
$3.39
52-wk low
$0.16
EPS
-$1.26
Beta
0.77
Shares outstanding
160.15M
No. of employees
17
News stories
From sources across the web
About Outlook Therapeutics Inc
CEO-
Employees17
Founded2010
Headquarters-
SectorBiotechnology
Websiteoutlooktherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to OTLK in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for OTLK in the last 3 months.
Highest
Current $1.57
$10.00 (+536.94%)
Average
$5.81 (+270.06%)
Lowest
$1.61 (+2.55%)
Analyst
Recommendation
Action
Price target
Projected
Date
Julian Harrison
BTIG
Hold
Reiterated
$1.61
+2.5%
06/29/2026
Edward Woo
Ascendiant
Buy
Maintained
$10.00
+536.9%
06/10/2026
Douglas Tsao
H.C. Wainwright
Hold
Reiterated
$0.50
-68.2%
04/08/2026
Daniil Gataulin
Chardan Capital
Hold
Maintained
$1.00
-36.3%
01/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.51M
-91.79K
-1.21M
127.44K
Cost of goods sold
7.57M
-20.29M
29.63K
149.33K
Cost of revenue
7.57M
-20.29M
29.63K
149.33K
Research and development expenses
-
27.18M
3.63M
4.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.68M
10.33M
8.61M
9.50M
Operating expense
9.68M
37.51M
12.25M
14.01M
Total operating expenses
17.25M
17.22M
12.28M
14.15M
Operating income
-15.75M
-17.31M
-13.48M
-14.03M
Other non operating income
-2.00M
3.02M
-2.79M
6.84M
EBT including unusual items
-20.15M
-14.85M
-23.06M
-4.45M
EBT excluding unusual items
-17.83M
-14.51M
-16.31M
-7.23M
Income tax expense
-
-1.55M
-
-
Effective tax rate
-
10.47%
-
-
Other operating expenses
-
-
-
-
Net income
-20.15M
-13.29M
-23.06M
-4.45M
Net profit margin
-1,338.75%
14,482.19%
1,909.05%
-3,494.28%
Earnings per share
-0.44
-0.29
-0.22
-0.17
Interest and investment income
-
89.74K
-
3.00
Interest expense
-49.35K
-264.16K
-
-
Net interest expenses
-49.35K
-174.42K
-
3.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.72M
-17.28M
-13.45M
-14.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer